Screening thousands of drugs, Stanford scientists determined that in mice, azlocillin, an antibiotic approved by the Food and Drug Administration, eliminated the bacteria that causes Lyme disease.
Source (https://med.stanford.edu/news/all-news/2020/03/potential-treatment-for-lingering-lyme-disease.html)